Hester Biosciences Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -

1,637.10 +15.30 (0.94%)Updated : 11 Nov 2025

Interim Data

Annual Data

Fiscal Period	2025	2024	2023	2022
Period End Date	Mar 25	Mar 24	Mar 23	Mar 22
Total Operating Expense	265.88	266.28	236.18	191.60
Other Net	0.40	5.73	11.78	10.68
Diluted Weighted Average Shares	0.85	0.85	0.85	0.85
Gain( Loss)on Saleof Assets	-0.49	0.03	0.02	0.13
Depreciation/ Amortization	16.80	17.17	20.70	16.58
Operating Income	45.22	38.26	29.91	43.41
Net Income	27.49	18.89	26.63	39.32
Income Availableto Com Excl Extra Ord	27.49	18.89	26.63	39.32
Other Operating Expenses Total	2.96	3.17	3.74	2.72
Net Income Before Taxes	39.57	31.95	40.15	53.50
Minority Interest	-1.34	-2.28	-1.41	-0.16
Net Income After Taxes	28.83	21.17	28.04	39.48
Income Availableto Com Incl Extra Ord	27.49	18.89	26.63	39.32
Costof Revenue Total	113.04	122.21	95.56	76.40
Gross Profit	198.06	182.34	170.53	158.61
Interest Inc( Exp) Net- Non- Op Total	-5.56	-12.07	-1.56	-0.71
Unusual Expense( Income)	0.00	-1.18	-	-
Diluted Net Income	27.49	18.89	26.63	39.32
DPS- Common Stock Primary Issue	7.00	6.00	8.00	10.00
Provisionfor Income Taxes	10.75	10.79	12.12	14.02
period Type	-	-	-	-
Net Income Before Extra Items	27.49	18.89	26.63	39.32
Total Revenue	311.10	304.55	266.09	235.01
period Length	12.00	12.00	12.00	12.00
Revenue	311.10	304.55	266.09	235.01
Selling/ General/ Admin Expenses Total	133.08	124.91	116.18	95.90
Diluted Normalized EPS	32.73	21.27	31.29	46.11
Diluted EPS Excluding Extra Ord Items	32.31	22.20	31.30	46.22